Crucial weeks ahead for Biocon amid growing competition in trastuzumab market, regulatory inspections
Updated : February 11, 2020 02:50 PM IST
Biocon in partnership with Mylan launched its version of trastuzumab in December 2019 in the US.
The company is expecting its Malaysian facility to be reinspected by the USFDA in February 2020.
Published : February 11, 2020 01:15 PM IST